Skip to main content
. 2024 Oct 7;6(4):1–10. doi: 10.46989/001c.124270

Figure 3A. The estimated 3-year OS for cohort-1 (CNS-/CB+) was 66% (95% CI: 56, 75) compared with 54% for cohort- 2 (CNS-/CB-); P=0.73).

Figure 3A.